FY2025 Results
• Revenue up (+€28.0 million), driven by demand in the defense and rail sectors, as well as the integration of FDB Industries during the fiscal year;
• EBITDA down to -€19.8 million, impacted by operational constraints and increased operating expenses;
• Continued sales momentum in 2026 for the defense and rail businesses;
• Implementation in April 2026 of a new bond financing of up to €45 million to support the Group's continued development;
• Ongoing discussions regarding the sale of the defense-related businesses;
• Insolvency proceedings initiated for the subsidiary Satma Industries and liquidation proceedings for the subsidiary FP Industries.
Read the press release (in French)
Number of shares and voting rights as at 31/05/2026
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st May.
Read the press release (in French)
Number of shares and voting rights as at 30/04/2026
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th April.
Read the press release (in French)
Implementation of a new bond financing and postponement of the publication of the Group’s 2025 financial statements
- Bond financing with a maximum nominal amount of €45 million over 36 months, in the form of OCBSA (bonds convertible into shares with warrants), implying potential dilution of more than 99% of the share capital
- Postponement of the publication of the Group’s 2025 financial statements
Read the press release (in French)
Number of shares and voting rights as at 31/03/2026
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st March.
Read the press release (in French)